BRAF V600E screening identifies candidates for perioperative therapy Skip to content The CRC Digest BRAF V600E screening identifies candidates for perioperative therapy Multicenter screening evaluated preoperative BRAF V600E mutation detection in patients with resectable colorectal oligometastases, enabling recruitment to a trial of the BEACON triplet regimen. (Int J Clin Oncol) This content is informational only and does not
Blood-Based ctDNA Testing May Help Monitor for Cancer Return After Surgery Skip to content The CRC Digest Blood-Based ctDNA Testing May Help Monitor for Cancer Return After Surgery Meta-analysis supports use of circulating tumor DNA as a biomarker to detect recurrence risk in patients who had liver metastases surgically removed. (Clinical Colorectal Cancer) This content is informational only and does not